Institute of Human Virology honors Dr. Raymond Schinazi with Lifetime Achievement Award September 23, 2016 by Brace Pharma Capital
Zymeworks Doses First Patient in Phase 1 Trial of ZW25, a Novel Bi-Specific Antibody September 21, 2016 by Brace Pharma Capital
Brace will be attending the BIO Investor Forum in San Francisco on October 18-19 2016 September 19, 2016 by Brace Pharma Capital
Brace will be attending the Cell & Gene Therapy meeting on October 5-7th 2016 September 18, 2016 by Brace Pharma Capital